It was suspected that the product might not meet quality requirements (out-of-specification results for lorazepam content and related substances), but testing of samples taken from the market confirmed correct quality of the batch. Potential effects: possible alteration of drug action, lack of efficacy or adverse effects.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Patients may use the medicine from this batch according to the doctor’s instructions; there is no need to return it or stop using it due to the quality of this batch.
The Chief Pharmaceutical Inspector declared the expiry of the 16.02.2023 decision suspending the batch from the market, after carrying out additional quality tests on samples taken from the market.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related